用Cenobamate来治疗异常性泛性:一个单一中心的经验和系统的文献审查
Nicole Woodrich1, Andreas Alexopoulos1, Dileep Nair1
1Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Epilepsia open
|October 7, 2025
概括
雪诺巴 (CNB) 显示出治疗耐药性异常性通用性 (IGE) 的前景. 这项研究发现,CNB有效地减少了IGE成年人的和急诊.
科学领域:
- 的研究研究.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 异形性通用性 (IGE) 通常呈现为耐药性,需要新的治疗策略.
- 塞诺巴 (CNB) 是一种具有新作用机制的抗药物.
- 关于在成年IGE群体中非标签使用CNB的数据有限.
研究的目的:
- 评估非标注的Cenobamate (CNB) 在成年患有异常性泛性 (IGE) 患者的疗效和耐受性.
- 在12个月内评估CNB保留率和发作频率的减少.
- 分析CNB对急诊室访问的影响,并确定常见的不良影响.
主要方法:
- 对16名成年IGE患者的电子健康记录的回顾性审查,这些患者接受了CNB治疗.
- 抽取发作频率,CNB保留数据和不良事件.
- 卡普兰-梅尔对CNB保留的生存分析;对比数据的系统文献综述.
主要成果:
- 57%的患者 (8/14) 实现了12个月CNB保留的主要结果.
- 在3-12个月后,在63%-86%的患者中观察到显著的发作减少 (≥50%);3名患者成为无发作.
- 中位数CNB保留时间为34个月;紧急访问在CNB启动后显著下降. 常见的副作用包括疲劳和头.
结论:
- 标签外Cenobamate (CNB) 的使用在减少发作频率和医疗保健利用率的成年人具有耐药性异常通用性 (IGE) 的有效性被证明.
- 对于难以治疗的IGE患者,CNB提供了一种潜在的治疗选择,需要进一步调查.
- 有利的保留率和扣押控制表明,中国央行在管理耐火IGE方面具有实用性.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
632
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
632
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists
893
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
893
Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822
Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K


